A detailed history of Susquehanna International Group, LLP transactions in Ocugen, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 640,745 shares of OCGN stock, worth $730,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares
640,745
Previous 1,197,099 46.48%
Holding current value
$730,449
Previous $1.96 Million 49.41%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$1.18 - $1.98 $656,497 - $1.1 Million
-556,354 Reduced 46.48%
640,745 $993,000
Q1 2024

May 07, 2024

BUY
$0.5 - $1.83 $425,754 - $1.56 Million
851,508 Added 246.39%
1,197,099 $1.96 Million
Q4 2023

Feb 14, 2024

SELL
$0.36 - $0.57 $28,515 - $45,149
-79,210 Reduced 18.65%
345,591 $196,000
Q3 2023

Nov 14, 2023

SELL
$0.4 - $0.62 $248,880 - $385,764
-622,200 Reduced 59.43%
424,801 $169,000
Q2 2023

Aug 11, 2023

SELL
$0.45 - $0.88 $618,267 - $1.21 Million
-1,373,928 Reduced 56.75%
1,047,001 $565,000
Q1 2023

May 16, 2023

BUY
$0.82 - $1.33 $1.63 Million - $2.64 Million
1,982,473 Added 452.15%
2,420,929 $2.06 Million
Q4 2022

Feb 14, 2023

SELL
$1.11 - $1.87 $858,671 - $1.45 Million
-773,578 Reduced 63.82%
438,456 $569,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $436,621 - $773,443
249,498 Added 25.92%
1,212,034 $2.16 Million
Q2 2022

Aug 15, 2022

SELL
$1.83 - $3.45 $1.39 Million - $2.63 Million
-760,935 Reduced 44.15%
962,536 $2.19 Million
Q1 2022

May 16, 2022

BUY
$2.34 - $4.72 $1.35 Million - $2.71 Million
574,805 Added 50.04%
1,723,471 $5.69 Million
Q4 2021

Feb 14, 2022

SELL
$4.38 - $15.67 $1.95 Million - $6.99 Million
-446,014 Reduced 27.97%
1,148,666 $5.23 Million
Q3 2021

Nov 15, 2021

BUY
$6.36 - $8.51 $1.74 Million - $2.33 Million
274,228 Added 20.77%
1,594,680 $11.5 Million
Q2 2021

Aug 11, 2021

SELL
$5.52 - $15.68 $137,961 - $391,890
-24,993 Reduced 1.86%
1,320,452 $10.6 Million
Q1 2021

May 17, 2021

BUY
$1.66 - $15.81 $2.23 Million - $21.3 Million
1,345,445 New
1,345,445 $9.14 Million
Q4 2020

Feb 16, 2021

SELL
$0.28 - $2.6 $6,168 - $57,283
-22,032 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$0.2 - $0.72 $4,406 - $15,863
22,032 New
22,032 $7,000
Q2 2020

Aug 14, 2020

SELL
$0.22 - $0.46 $33,131 - $69,274
-150,597 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.26 - $0.73 $39,155 - $109,935
150,597 New
150,597 $42,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $247M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.